Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Masonic Cancer Center, University of Minnesota
Children's Hospital Medical Center, Cincinnati
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Masonic Cancer Center, University of Minnesota
University of Washington
OHSU Knight Cancer Institute
Cellerant Therapeutics
National Cancer Institute (NCI)
M.D. Anderson Cancer Center